Portfolio: Investments

Solasia Pharma K.K.
Specialty pharmaceuticals, oncology

Somaxon Pharmaceuticals, Inc.
Specialty pharmaceuticals for neurology and psychiatry

Swedish Orphan BioVitrum
Acquired Swedish Orphan International Holding AB to create Swedish Orphan BioVitrum

Syndax Pharmaceuticals, Inc.
Novel combination regimens for cancer

Theraclone Sciences
Novel tumor-specific therapeutic antibodies

TriVascular, Inc.
Novel endovascular repair devices to treat abdominal aortic aneurysms